Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Karen Salvesen Sykes"'
1
Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase‐4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials
Autor: Karen Salvesen-Sykes, Petra Őrsy, Karolina Stachlewska, Athena Philis-Tsimikas, Andrej Janez, Liana K. Billings
Publikováno v: Diabetes, Obesity & Metabolism
Aim To investigate the efficacy and safety of initiating insulin degludec/liraglutide (IDegLira) in patients with type 2 diabetes (T2D) who had discontinued pretrial sulphonylureas (SUs) or dipeptidyl peptidase‐4 inhibitors (DPP4is) versus patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e42a11f2f68a49592638e45b4dfc998
https://doi.org/10.1111/dom.13944
Zobrazit plný text záznamu
2
Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin‐treated type 2 diabetes
Autor: Karen Salvesen-Sykes, Johan Ejstrud, Milivoj Piletič, Keith Bowering, James Snyder, Anne L. Peters
Publikováno v: Diabetes, Obesity & Metabolism
This post hoc analysis of an 18‐week randomized trial explored the utility of calculating baseline glycated haemoglobin (HbA1c), postprandial glucose (PPG) increments and nocturnal glucose change in predicting efficacy and safety outcomes in respon
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50129bb6875dfe7b8759a0256dde97d
https://doi.org/10.1111/dom.13729
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje